Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9304)
All Articles published online
|
Publishing Process of This Article
|
Sep 14, 2018 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou J, Chng WJ. Resistance to FLT3 inhibitors in acute myeloid leukemia: Molecular mechanisms and resensitizing strategies. World J Clin Oncol 2018; 9(5): 90-97 [PMID: 30254964 DOI: 10.5306/wjco.v9.i5.90] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v9/i5/90.htm |
| Number | Citing Articles |
| 1 |
Xianwen Yang, Molly Pui Man Wong, Ray Kit Ng. Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications. International Journal of Molecular Sciences 2019; 20(18): 4576 doi: 10.3390/ijms20184576
|
| 2 |
Motoki Eguchi, Yosuke Minami, Ayumi Kuzume, SungGi Chi. Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia. Biomedicines 2020; 8(8): 245 doi: 10.3390/biomedicines8080245
|
| 3 |
Muhammad Usama Tariq. 'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine. 2020; : 71 doi: 10.1007/978-981-15-1067-0_3
|
| 4 |
Iuliana Iordan, Anca Nicolescu, Irina Voican, Minodora Onisâi, Ana Maria Vlădăreanu. FLT3-positive acute myeloid leukemia: an example of personalized approach. Oncolog-Hematolog.ro 2020; 4(53): 16 doi: 10.26416/OnHe.53.4.2020.4045
|
| 5 |
Wolf‐Karsten Hofmann, Andreas Trumpp, Carsten Müller‐Tidow. Therapy resistance mechanisms in hematological malignancies. International Journal of Cancer 2023; 152(3): 340 doi: 10.1002/ijc.34243
|
| 6 |
Maëlle Cartel, Pierre-Luc Mouchel, Mathilde Gotanègre, Laure David, Sarah Bertoli, Véronique Mansat-De Mas, Arnaud Besson, Jean-Emmanuel Sarry, Stéphane Manenti, Christine Didier. Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy. Leukemia 2021; 35(2): 417 doi: 10.1038/s41375-020-0878-x
|
| 7 |
Yi Xu, Kimberly Payne, Linh Hoang Gia Pham, Park Eunwoo, Jeffrey Xiao, David Chi, Justin Lyu, Rosalia Campion, Samiksha Wasnik, Il Seok Jeong, Xiaolei Tang, David Jeston Baylink, Chien Shing Chen, Mark Reeves, Mojtaba Akhtari, Saied Mirshahidi, Guido Marcucci, Huynh Cao. A novel vitamin D gene therapy for acute myeloid leukemia. Translational Oncology 2020; 13(12): 100869 doi: 10.1016/j.tranon.2020.100869
|
| 8 |
Amin Huang, Peiting Zeng, Yinguang Li, Wenhua Lu, Yaoming Lai. LY294002 Is a Promising Inhibitor to Overcome Sorafenib Resistance in FLT3-ITD Mutant AML Cells by Interfering With PI3K/Akt Signaling Pathway. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.782065
|
| 9 |
Eman M.E. Dokla, Amal Kamal Abdel-Aziz, Sandra N. Milik, Martin J. McPhillie, Saverio Minucci, Khaled A.M. Abouzid. Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia. Bioorganic & Medicinal Chemistry 2022; 56: 116596 doi: 10.1016/j.bmc.2021.116596
|
| 10 |
Cristina Papayannidis, Chiara Sartor, Giovanni Marconi, Maria Chiara Fontana, Jacopo Nanni, Gianluca Cristiano, Sarah Parisi, Stefania Paolini, Antonio Curti. Acute Myeloid Leukemia Mutations: Therapeutic Implications. International Journal of Molecular Sciences 2019; 20(11): 2721 doi: 10.3390/ijms20112721
|
| 11 |
Luyao Long, Yehuda G. Assaraf, Zi-Ning Lei, Hongwei Peng, Lin Yang, Zhe-Sheng Chen, Simei Ren. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia. Drug Resistance Updates 2020; 52: 100703 doi: 10.1016/j.drup.2020.100703
|
| 12 |
Bo-Reum Kim, Seung-Hyun Jung, A-Reum Han, Gyeongsin Park, Hee-Je Kim, Bin Yuan, Venkata Lokesh Battula, Michael Andreeff, Marina Konopleva, Yeun-Jun Chung, Byung-Sik Cho. CXCR4 Inhibition Enhances Efficacy of FLT3 Inhibitors in FLT3-Mutated AML Augmented by Suppressed TGF-β Signaling. Cancers 2020; 12(7): 1737 doi: 10.3390/cancers12071737
|
| 13 |
Adrián Mosquera Orgueira, Laura Bao Pérez, Alicia Mosquera Torre, Andrés Peleteiro Raíndo, Miguel Cid López, José Á. Díaz Arias, Roi Ferreiro Ferro, Beatriz Antelo Rodríguez, Marta S. González Pérez, Manuel Albors Ferreiro, Natalia Alonso Vence, Manuel M. Pérez Encinas, José L. Bello López, Giovanni Martinelli, Claudio Cerchione. FLT3 inhibitors in the treatment of acute myeloid leukemia: current status and future perspectives. Minerva Medica 2020; 111(5) doi: 10.23736/S0026-4806.20.06989-X
|
| 14 |
Jiali Zhu, Tao Yang, Minghai Tang, Zhuang Yang, Heying Pei, Haoyu Ye, Yu Tang, Zhixuan Cheng, Ping Lin, Lijuan Chen. Studies on the anti-psoriasis effects and its mechanism of a dual JAK2/FLT3 inhibitor flonoltinib maleate. Biomedicine & Pharmacotherapy 2021; 137: 111373 doi: 10.1016/j.biopha.2021.111373
|
| 15 |
Abel Tesfaye Anshabo, Laychiluh Bantie, Sarah Diab, Jimma Lenjisa, Alemwork Kebede, Yi Long, Gary Heinemann, Jasmine Karanjia, Benjamin Noll, Sunita K. C. Basnet, Manjun Li, Robert Milne, Hugo Albrecht, Shudong Wang. An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia. Cancers 2022; 14(5): 1113 doi: 10.3390/cancers14051113
|
| 16 |
Joshua J. Lara, Alfonso E. Bencomo-Alvarez, Mayra A. Gonzalez, Idaly M. Olivas, James E. Young, Jose L. Lopez, Vanessa V. Velazquez, Steven Glovier, Mehrshad Keivan, Andres J. Rubio, Sara K. Dang, Jonathan P. Solecki, Jesse C. Allen, Desiree N. Tapia, Boranai Tychhon, Gonzalo E. Astudillo, Connor Jordan, Darshan S. Chandrashekar, Anna M. Eiring. 19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML). International Journal of Molecular Sciences 2022; 23(23): 14586 doi: 10.3390/ijms232314586
|